Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.

ग्रंथसूची विवरण
मुख्य लेखकों:	Jeyakumar, M, Thomas, R, Elliot-Smith, E, Smith, D, van der Spoel, A, d'Azzo, A, Perry, V, Butters, T, Dwek, R, Platt, F
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2003

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.
द्वारा: Elliot-Smith, E, और अन्य
प्रकाशित: (2008)

GM1 Gangliosidosis—A Mini-Review
द्वारा: Elena-Raluca Nicoli, और अन्य
प्रकाशित: (2021-09-01)

N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis
द्वारा: Kasperzyk, J, और अन्य
प्रकाशित: (2004)

N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
द्वारा: Kasperzyk, J, और अन्य
प्रकाशित: (2004)

Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice
द्वारा: J.L. Kasperzyk, और अन्य
प्रकाशित: (2005-04-01)

Characterization of glycan substrates accumulating in GM1 Gangliosidosis
द्वारा: Roger Lawrence, और अन्य
प्रकाशित: (2019-12-01)

"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
द्वारा: Kasperzyk, J, और अन्य
प्रकाशित: (2005)

Erratum: Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice (Journal of Lipid Research (April 2004) 46 (744-751))
द्वारा: Kasperzyk, J, और अन्य
प्रकाशित: (2005)

Filipin recognizes both GM1 and cholesterol in GM1 gangliosidosis mouse brain
द्वारा: Julian R. Arthur, और अन्य
प्रकाशित: (2011-07-01)

GM1 Gangliosidosis: Mechanisms and Management
द्वारा: Rha AK, और अन्य
प्रकाशित: (2021-04-01)

GM1 gangliosidosis: a case report
द्वारा: Guilherme Dienstmann, और अन्य
प्रकाशित: (2021-11-01)

Therapeutic developments for neurodegenerative GM1 gangliosidosis
द्वारा: Dorian Foster, और अन्य
प्रकाशित: (2024-04-01)

Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
द्वारा: Maria L. Allende, और अन्य
प्रकाशित: (2023-12-01)

Pathological findings of central nervous system, two GM1 gangliosidosis autopsy cases
द्वारा: Doğuş Özdemir Kara, और अन्य
प्रकाशित: (2019-12-01)

Altered GM1 catabolism affects NMDAR-mediated Ca2+ signaling at ER-PM junctions and increases synaptic spine formation in a GM1-gangliosidosis model
द्वारा: Jason A. Weesner, और अन्य
प्रकाशित: (2024-05-01)

GM1 Gangliosidosis Type 1 and Mongolian Spots
द्वारा: J Gordon Millichap
प्रकाशित: (2013-06-01)

Wishbone sign in GM1 type III gangliosidosis
द्वारा: Ayush Agarwal, और अन्य
प्रकाशित: (2023-01-01)

Animal models of GM2 gangliosidosis: utility and limitations
द्वारा: Lawson CA, और अन्य
प्रकाशित: (2016-07-01)

Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis)
द्वारा: Kunihiko Suzuki, और अन्य
प्रकाशित: (1967-03-01)

AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival.
द्वारा: Rena C Baek, और अन्य
प्रकाशित: (2010-10-01)

An Evalution of the Demographic and Clinical Characterictics of Patients with GM2 Gangliosidosis
द्वारा: Esra Er, और अन्य
प्रकाशित: (2018-03-01)

Progressive dystonia as a presenting manifestation of GM1 gangliosidosis
द्वारा: Sahil Mehta, और अन्य
प्रकाशित: (2019-01-01)

Clinical findings in Brazilian patients with adult GM1 gangliosidosis
द्वारा: Luciana Giugliani, और अन्य
प्रकाशित: (2019-09-01)

Biochemical characterization of the GM2 gangliosidosis B1 variant
द्वारा: J.C. Tutor
प्रकाशित: (2004-06-01)

Persistent elevations of alkaline phosphatase as an early indicator of GM1 gangliosidosis
द्वारा: Iskren Menkovic, और अन्य
प्रकाशित: (2025-03-01)

Therapeutic assessment of substrate deprivation using NB-DGJ in GM1 storage disease mice
द्वारा: Seyfried, T, और अन्य
प्रकाशित: (2003)

Preclinical Enzyme Replacement Therapy with a Recombinant β-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis
द्वारा: Jason Andrew Weesner, और अन्य
प्रकाशित: (2022-08-01)

GM1 - gangliosidosis in a Nigerian infant: A case report
द्वारा: Abdullahi M Sakina, और अन्य
प्रकाशित: (2021-03-01)

Case report: Preimplantation genetic testing for infantile GM1 gangliosidosis
द्वारा: Valeria A. Zagaynova, और अन्य
प्रकाशित: (2024-02-01)

Substrate deprivation therapy reduces brain ganglioside content and GM1 in neonatal storage disease mice
द्वारा: Kasperzyk, J, और अन्य
प्रकाशित: (2002)

GM2-gangliosidosis, type I (Tay – Sachs disease) in the pediatrician practice
द्वारा: Natalia V. Zhurkova, और अन्य
प्रकाशित: (2021-01-01)

Enzyme-responsive polymersomes ameliorate autophagic failure in a cellular model of GM1 gangliosidosis
द्वारा: Bipin Chakravarthy Paruchuri, और अन्य
प्रकाशित: (2022-10-01)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
द्वारा: Pshezhetsky, A, और अन्य
प्रकाशित: (2017)

Molecular Analysis of 9 Unrelated Families Presenting With Juvenile and Chronic GM1 Gangliosidosis
द्वारा: Marcella B. Baptista MSc, और अन्य
प्रकाशित: (2016-04-01)

Genetic Analysis of Undiagnosed Juvenile GM1-Gangliosidosis by Microarray and Exome Sequencing
द्वारा: Ahmed Bouhouche, और अन्य
प्रकाशित: (2018-01-01)

Extensive telangiectasias and mongolian spots: A clue towards GM1-gangliosidosis
द्वारा: Sachin Gupta, और अन्य
प्रकाशित: (2023-01-01)

Feasibility study of cyclodextrins as active pharmaceutical ingredients for the treatment of GM1-gangliosidosis
द्वारा: Yuki Maeda, और अन्य
प्रकाशित: (2016-02-01)

Combined deficiencies of endosomal ganglioside neuraminidases 3 and 4 in mice cause lysosomal GM3 gangliosidosis
द्वारा: Pshezhetsky, A, और अन्य
प्रकाशित: (2017)

Clinical and imaging predictors of late‐onset GM2 gangliosidosis: A scoping review
द्वारा: Neha P. Godbole, और अन्य
प्रकाशित: (2024-01-01)

Single Institutional Experience with GM1 Gangliosidosis: Clinical and Laboratory Results of 14 Patients
द्वारा: Halil Tuna Akar, और अन्य
प्रकाशित: (2022-09-01)

Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.

समान संसाधन

समान संसाधन